Brian Stemme is listed as a director on 9 SEC Form D filings by 2 issuers between Apr 2010 and Jun 2016: AgeneBio, Inc. (Baltimore, MD — biotechnology — 2010–2013; $4.11M reported sold to 27 investors) and Algaeon, Inc. (Indianapolis, IN — biotechnology — 2014–2016; $771K reported sold to 25 investors).
What this means 2 separate companies raised money with this person listed as director, over about 6 years. Across those companies the filings report $4.88M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 9 public filings for Brian Stemme and found 7 differences: Offering amount changed between filings; 5 offerings have no amendment in the last 12 months and may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.